| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.21560 |
| P698 | PubMed publication ID | 16385496 |
| P50 | author | Cynthia S Crowson | Q87215892 |
| Hilal Maradit Kremers | Q88386643 | ||
| Paulo Nicola | Q88783656 | ||
| Véronique L. Roger | Q110955107 | ||
| Steven J Jacobsen | Q37384936 | ||
| Karla V Ballman | Q48925439 | ||
| P2093 | author name string | Sherine E Gabriel | |
| P2860 | cites work | The incidence and prevalence of congestive heart failure in Rochester, Minnesota. | Q50605297 |
| Trends in the Incidence and Survival of Patients with Hospitalized Myocardial Infarction, Olmsted County, Minnesota, 1979 to 1994 | Q57540371 | ||
| Chloroquine cardiomyopathy with conduction disorders | Q28369555 | ||
| Cardiac involvement in rheumatoid disease. | Q34254088 | ||
| Survival after the onset of congestive heart failure in Framingham Heart Study subjects | Q38512499 | ||
| Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996. | Q43992493 | ||
| P433 | issue | 1 | |
| P921 | main subject | immunology | Q101929 |
| heart failure | Q181754 | ||
| rheumatoid arthritis | Q187255 | ||
| rheumatology | Q327657 | ||
| coronary artery disease | Q844935 | ||
| Excess mortality | Q98840270 | ||
| congestive heart failure | Q19000661 | ||
| P304 | page(s) | 60-67 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis | |
| P478 | volume | 54 |
| Q95359377 | Q95359377 |
| Q52587395 | Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. |
| Q42374261 | Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis |
| Q87035377 | Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis |
| Q34346209 | Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study |
| Q35460930 | Association of TNFSF8 polymorphisms with peripheral neutrophil count |
| Q48646872 | Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging |
| Q33721605 | Autoantibodies and the risk of cardiovascular events |
| Q38898838 | Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad. |
| Q33898103 | Biologics and heart failure in rheumatoid arthritis: are we any wiser? |
| Q38876331 | Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment. |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q33806651 | Cardiovascular morbidity and mortality in rheumatoid arthritis |
| Q34316084 | Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention |
| Q30426026 | Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial |
| Q49493173 | Coronary Artery Inflammation in Rheumatoid Arthritis Using Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography |
| Q38045857 | Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review |
| Q79487694 | Do antirheumatic drugs increase the risk of acute myocardial infarction? |
| Q41868896 | Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management |
| Q30401698 | Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography |
| Q92589114 | Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review |
| Q36742762 | Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists |
| Q28480869 | High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation |
| Q33637906 | Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study |
| Q51781155 | Increased occurrence of cardiovascular events and comorbidities in a general rheumatology cohort. |
| Q34061175 | Increased prevalence of diastolic dysfunction in rheumatoid arthritis. |
| Q37060522 | Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction |
| Q38393039 | Innate immunity and the failing heart: the cytokine hypothesis revisited |
| Q35656020 | Lack of association of oral calcium supplementation with coronary artery calcification in rheumatoid arthritis |
| Q48576327 | Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study. |
| Q45265863 | Left ventricular morphology and function in patients with rheumatoid arthritis |
| Q34433298 | Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging |
| Q26829955 | My treatment approach to rheumatoid arthritis |
| Q58574869 | Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) is Associated with Disease Activity in Rheumatoid Arthritis |
| Q33695937 | Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers |
| Q92771536 | Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis |
| Q37730557 | Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. |
| Q44687811 | Preclinical impairment of myocardial function in rheumatoid arthritis patients. Detection of myocardial strain by speckle tracking echocardiography |
| Q35620858 | Predictors of diastolic dysfunction in rheumatoid arthritis |
| Q51572553 | Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks. |
| Q37140079 | Rheumatoid arthritis and cardiovascular disease |
| Q35815364 | Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study |
| Q41176187 | Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides |
| Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
| Q93083351 | Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study |
| Q41264898 | Sudden cardiac death in patients with rheumatoid arthritis |
| Q48214698 | The Impact of Different Classification Criteria Sets on the Estimated Prevalence and Associated Risk Factors of Diastolic Dysfunction in Rheumatoid Arthritis |
| Q37027093 | The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases |
| Q34153010 | The delivery of evidence-based preventive care for older Americans with arthritis |
| Q38420988 | The epidemiology of rheumatoid arthritis in Ontario, Canada |
| Q36596365 | The heart and cardiovascular manifestations in rheumatoid arthritis |
| Q37691038 | The phenotype and genotype of rheumatoid arthritis in the Democratic Republic of Congo. |
| Q37074034 | The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. |
| Q35669374 | Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis |
| Q35954625 | What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. |
| Q80314055 | [Rheumatoid arthritis and cardiovascular complications] |
Search more.